SENSITIVITY OF THE FIBRINOGEN CLOTTING TIME - AN IN-VITRO TEST OF POTENTIAL THROMBOGENICITY

被引:4
作者
FELDMAN, PA [1 ]
MCGRATH, S [1 ]
EVANS, H [1 ]
机构
[1] CHURCHILL HOSP,PLASMA FRACTIONAT LAB,BPL,OXFORD,ENGLAND
关键词
D O I
10.1111/j.1423-0410.1994.tb00268.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The fibrinogen clotting time (FCT) is a measure of thrombin activity, and is used to evaluate the potential thrombogenicity of prothrombin complex concentrates (PCC). We have defined end points for clot formation in this test which allow the measurement in PCC of thrombin concentrations as low as 0.001 IU/ml. The FCT of thrombin and PCC samples which did not contain antithrombin III (ATIII) were the same when measured at 20 degrees C or 37 degrees C. In the presence of ATIII (0.05 or 0.25 IU/ml), samples of PCC which were known to contain thrombin showed shorter FCT at 20 degrees C than at 37 degrees C. Inclusion of both ATIII (0.25 IU/ml) and heparin (4 IU/ml) in PCC ensured the complete inactivation of endogenous thrombin.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 12 条
[1]   PREPARATION AND CLINICAL USE OF A NEW CONCENTRATE CONTAINING FACTOR IX, PROTHROMBIN AND FACTOR-X AND OF A SEPARATE CONCENTRATE CONTAINING FACTOR VII [J].
DIKE, GWR ;
BIDWELL, E ;
RIZZA, CR .
BRITISH JOURNAL OF HAEMATOLOGY, 1972, 22 (04) :469-+
[2]  
FELDMAN P, 1991, BLOOD SEPARATION PLA, P341
[3]  
FELDMAN P A, 1990, British Journal of Haematology, V76, P16
[4]  
HRINDA ME, 1991, SEMIN HEMATOL, V28, P6
[5]   THROMBOEMBOLIC COMPLICATIONS [J].
KASPER, CK .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 33 (03) :640-644
[6]  
MENACHE D, 1984, BLOOD, V64, P1220
[7]   SUMMARY REPORT AND RECOMMENDATIONS OF TASK FORCE MEMBERS AND CONSULTANTS [J].
MENACHE, D ;
ROBERTS, HR .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 33 (03) :645-647
[8]   LARGE-SCALE PRODUCTION AND PROPERTIES OF A SOLVENT-DETERGENT-TREATED FACTOR-IX CONCENTRATE FROM HUMAN-PLASMA [J].
MICHALSKI, C ;
BAL, F ;
BURNOUF, T ;
GOUDEMAND, M .
VOX SANGUINIS, 1988, 55 (04) :202-210
[9]   INVITRO SPONTANEOUS THROMBIN GENERATION IN HUMAN FACTOR-9 CONCENTRATES [J].
SAS, G ;
OWENS, RE ;
SMITH, JK ;
MIDDLETON, S ;
CASH, JD .
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 31 (01) :25-35
[10]   A PASTEURIZED ANTITHROMBIN-III CONCENTRATE FOR CLINICAL USE [J].
SMITH, JK ;
WINKELMAN, L ;
EVANS, DR ;
HADDON, ME ;
SIMS, G .
VOX SANGUINIS, 1985, 48 (06) :325-332